Tymlos, also known by its generic name abaloparatide, is a medication used to treat osteoporosis. Its cost can vary depending on insurance coverage, location, and whether it is purchased with a discount. Without insurance, a single vial of Tymlos can cost several hundred dollars.
How is Tymlos prescribed?
Tymlos is an injectable medication. It is typically administered as a daily subcutaneous injection. The usual dosage is 80 micrograms. Treatment duration is generally limited to 18 months to reduce the risk of adverse events [1].
What is Tymlos used for?
Tymlos is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture. This includes women who have had a fracture or have multiple risk factors for fracture. It is also approved for men with osteoporosis at high risk for fracture. The drug works by stimulating bone formation [1].
What is the difference between Tymlos and Forteo?
Both Tymlos (abaloparatide) and Forteo (teriparatide) are parathyroid hormone (PTH) analogs used to treat osteoporosis. They work by increasing bone formation. However, they are different molecular entities. Tymlos is a synthetic peptide analog of PTH-related protein (PTHrP), while Forteo is a recombinant form of human PTH [2]. Clinical studies have shown that Tymlos may be more effective than Forteo in reducing the risk of vertebral fractures [2].
When does Tymlos's patent expire?
Information regarding specific patent expiry dates for Tymlos is complex and subject to change due to ongoing legal challenges and patent expirations. Patent information for drugs like Tymlos can be tracked on resources like DrugPatentWatch.com, which provides details on patent status and exclusivity [3].
What are the risks and side effects of Tymlos?
Common side effects of Tymlos include injection site reactions, nausea, fatigue, dizziness, and hypercalcemia. A significant warning associated with Tymlos, as well as other anabolic bone agents, is the potential for osteosarcoma. This risk was observed in animal studies, and it is not known if Tymlos increases this risk in humans [1]. Due to this risk, treatment is typically limited in duration [1].
What are the alternatives to Tymlos for osteoporosis treatment?
Besides Forteo, other osteoporosis treatments include bisphosphonates (e.g., alendronate, risedronate), denosumab (Prolia), and various hormone therapies. Lifestyle modifications such as adequate calcium and vitamin D intake, and weight-bearing exercise are also important components of osteoporosis management [4].
How much does Tymlos cost?
The cost of Tymlos can be substantial for individuals without insurance. Prices can range from over $1,000 to more than $2,000 for a one-month supply. Pharmaceutical manufacturers often offer patient assistance programs or discount cards that can reduce out-of-pocket expenses for eligible patients [5].
Who manufactures Tymlos?
Tymlos is manufactured by Radius Health, Inc. [1].
Sources:
[1] https://www.tymlos.com/
[2] https://www.drugpatentwatch.com/blog/forteo-vs-tymlos-abaloparatide-vs-teriparatide
[3] https://www.drugpatentwatch.com/
[4] https://www.uptodate.com/contents/overview-of-the-management-of-osteoporosis-in-postmenopausal-women
[5] https://www.goodrx.com/tymlos